Online weight loss treatment in Vermont
Surfbound connects eligible adults in Vermont with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Vermont?
Yes. Eligible adults across Vermont can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Vermont reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Vermont address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Green Mountain State · Northeast region. A rural state with limited obesity-medicine options. Telehealth-first across rural Vermont.
Coverage across Vermont
Care is delivered entirely online across Vermont, so you can start from anywhere in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Vermont
Prescriptions for Vermont patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the Northeast region, from Burlington, Montpelier, Rutland to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.
What's included in every Vermont plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Vermont coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Vermont. The Vermont provider access & process page covers the clinical steps in detail.
Care is delivered online across Vermont, so you can start from anywhere in the state — no in-person visit is required.
The Vermont telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Vermont. You complete a health intake online, and a licensed provider credentialed in Vermont reviews your information remotely.
Vermont permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Vermont may review a Vermont patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Vermont” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Vermont license issued by the Vermont Board of Medical Practice, and any pharmacy filling your prescription must be licensed in Vermont. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Vermont” section on this page.
Across Vermont, semaglutide runs $169/mo and tirzepatide $219/mo — one flat rate that covers the Vermont-licensed provider review. There is no membership fee, and the total appears before checkout.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No — in Vermont, medication is dispensed only when the reviewing provider finds treatment medically appropriate.
Yes — Vermont residents can transfer an existing GLP-1 plan. Note your medication and dose in the intake, and the reviewing Vermont provider determines the prescription after assessing whether a dose match is appropriate.
The GLP-1 total-cost calculator compares equal monthly recurring cost — membership, shipping and dose surcharges for any plan — against Surfbound's flat Vermont rate, so Vermont residents compare complete costs rather than a headline number.
Compounded semaglutide is one of the two GLP-1 options available across Vermont, priced flat each month with the provider review included. Nothing ships unless a Vermont-licensed provider approves treatment. It is not an FDA-approved medication.
Tirzepatide is available to Vermont residents and reviewed the same way as semaglutide. The provider review is included in the monthly price, and treatment is dispensed only when a Vermont-licensed provider finds it appropriate. Compounded tirzepatide is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Vermont residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Vermont-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Vermont. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Vermont provider approves your medication. A rural state with limited obesity-medicine options.
Yes. Vermont residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Vermont provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Vermont with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Vermont-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Vermont residents complete a short online intake on their own schedule, and a Vermont-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. A rural state with limited obesity-medicine options. Telehealth-first across rural Vermont.
Yes. Men across Vermont begin with a private online intake, a licensed Vermont provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Vermont residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Vermont
What governs a provider treating a Vermont patient online, and where you can check it yourself.
State medical board
Vermont Board of Medical PracticeVermont Board of Medical Practice licenses the providers who review Vermont intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Vermont Statutes Annotated Title 26, Chapter 23Opens the official Vermont code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Vermont license to evaluate or treat a patient who is physically located in Vermont. Every Vermont intake is routed to a provider credentialed in Vermont, and a prescription is issued only when that provider determines treatment is medically appropriate.
Vermont permits telemedicine prescribing when a proper provider-patient relationship has been established. The state has been progressive in telehealth regulation, recognizing its importance for rural populations.
Surfbound is an online service. We do not have physical offices in Vermont. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Vermont and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Vermont state government agency. Provider licensure in Vermont is governed by the Vermont Board of Medical Practice.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.